Series A - Kala Pharmaceuticals - Feb 28, 2013 Funding Round Profile - Cointime

Bitcoin $99,021.20 +0.81%
Ethereum $3,303.13 -1.32%
BNB $624.69 +0.83%
Optimism $2.13 +2.95%
Arbitrum $0.79 +0.78%
Solana $254.64 -0.98%
Polygon $0.48 +6.81%
Cosmos $7.33 +16.35%
Avalanche $39.71 +11.23%

Bitcoin $99,021.20 +0.81%
Ethereum $3,303.13 -1.32%
BNB $624.69 +0.83%
Optimism $2.13 +2.95%
Arbitrum $0.79 +0.78%
Solana $254.64 -0.98%
Polygon $0.48 +6.81%
Cosmos $7.33 +16.35%
Avalanche $39.71 +11.23%

Kala Pharmaceuticals

company

Funding Round

Series A

Money Raised

$ 11.50M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Crown Venture Fund	-	Yes	-	Detail
Lux Capital	-	-	-	Detail
Polaris Partners	-	-	-	Detail
Third Rock Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 24, 2009	Series A	$ 2M		Detail
Mar 14, 2012	Private Equity（PE）	$ 7.24M	Lighthouse Capital Partners,Lux Capital,etc.	Detail
Nov 10, 2010	Series Unknown	$ 3M		Detail